Like AMD, MPGNII is a disease of the ECM, where defects in the regulation of the alternative pathway of complement, either by genetic alterations in genes including CFH, or the presence of auto-antibodies against FH, lead to deposits in the basement membranes of the glomeruli [9]. The gene discussed is CFH; the disease is age-related macular degeneration.